The effect of doxazosin on sexual function in patients with benign prostatic hyperplasia, hypertension, or both

International Journal of Clinical Practice

Volumn 56, Issue 7, 2002, Pages 527-530

  Flack, John M ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTIANDROGEN; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; FINASTERIDE; PLACEBO; PROPRANOLOL; TAMSULOSIN; THIAZIDE DIURETIC AGENT;

AGED; AGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DRUG FORMULATION; DRUG INDICATION; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; PREVALENCE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; SEXUAL DYSFUNCTION; TRANSURETHRAL RESECTION;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; DOXAZOSIN; HUMANS; HYPERTENSION; IMPOTENCE; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; QUALITY OF LIFE;

EID: 0036733407     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Benign prostatic hyperplasia: Its natural history, epidemiologic characteristics, and surgical treatment
2. Benign prostatic hyperplasia: Practical treatment guidelines
3. The development of benign prostatic hyperplasia
4. The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension
5. Doxazosin for benign prostatic hyperplasia in primary care
6. Sexual dysfunction in men with lower urinary tract symptoms
7. The evaluation of sexual function in men presenting with symptomatic benign prostatic hyperplasia
8. Impotence. NIH Consensus Development Panel on Impotence
9. Erectile dysfunction: Are you prepared to discuss it?
10. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women
11. Effect of antihypertensives on sexual function and quality of life: The TAIM Study
12. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study
13. Effects of SSRIs on sexual function: A critical review
14. Sexual side effects of antidepressants: A review
15. Sexual satisfaction and dysfunction in marriages of male alcoholics: Comparison with nonalcoholic maritally conflicted and nonconflicted couples
16. Sexual function of men ages 40 to 79 years: The Olmsted County study of urinary symptoms and health status among men
17. 1-adrenoceptor antagonists
18. The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy
19. Benign prostatic hyperplasia: Effects on quality of life and impact on treatment decisions
20. Patient reports of symptoms and quality of life following prostate surgery
21. On life satisfaction in male erectile dysfunction
22. Erectile function following transurethral prostatectomy
23. Sexual function after transurethral prostatectomy
24. Effects of prostatectomy on sexual function
25. Relative importance of sexuality and quality of life in patients with prostatic symptoms: Results of an international study
26. BPH and sexuality
27. Natural history of prostatism: Impact of urinary symptoms on quality of life in 2115 randomly selected community men
28. The American Urological Association symptom index for benign prostatic hyperplasia
29. LUTS, ED, QOL: Alphabet soup or real concerns to aging men?
30. Benign prostatic hyperplasia: Diagnosis and treatment. Benign Prostatic Hyperplasia Guideline Panel
31. Efficacy, tolerability, and effect on health-related quality of life of finasteride versus placebo in men with symptomatic benign prostatic hyperplasia: A community based study
32. Long-term evaluation of tamsulosin in benign prostatic hyperplasia: Placebo-controlled, double-blind extension of phase III trial
33. Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia
34. Medical therapy for benign prostatic hyperplasia: A review of the literature
35. 29-week doxazosin treatment in patients with symptomatic benign prostatic hyperplasia: A double-blind placebo-controlled study
36. Erectile dysfunction following treatments of benign prostatic hyperplasia: A prospective study
37. Doxazosin GITS and doxazosin standard in patients with benign prostatic hyperplasia: Double blind trial of efficacy and tolerability
38. A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia
39. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction
40. Sexual dysfunction in hypertensive men: A critical review of the literature
41. Sexual dysfunction with aging and systemic hypertension
42. Effects of antihypertensive agents on sexual function
43. Medical Research Council working party on mild to moderate hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension
44. The impact of diuretic therapy on reported sexual function
45. Long-term surveillance for adverse effects of antihypertensive drugs
46. Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT): Six-year intervention results for men in special intervention and usual care groups
47. Physiology of penile erection
48. Alpha-blockade: Monotherapy for hypertension and benign prostatic hyperplasia